Company profile: Parse Biosciences
1.1 - Company Overview
Company description
- Provider of single-cell sequencing kits and data analysis software for researchers, including Evercode Whole Transcriptome (instrument-free, scalable from thousands to millions of cells), Evercode Immune Profiling (TCR/BCR sequencing), CRISPR Detect (gRNA plus gene expression in up to one million cells), Gene Capture (targeted scRNA-seq panels), and software integrating with NGS platforms.
Products and services
- CRISPR Detect: Million-cell-scale assay that detects gRNA alongside gene expression per single cell, enabling readouts in up to one million single cells per experiment
- Evercode Immune Profiling: Kit-based TCR and BCR sequencing system that architects immune repertoire insights from samples through sequencing for receptor profiling
- Evercode Whole Transcriptome: Instrument-free single-cell sequencing product that delivers scalable whole-transcriptome sequencing, suitable for projects from thousands to millions of cells
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Parse Biosciences
Counsyl
HQ: United States
Website
- Description: Provider of DNA screening for men, women, and their children, focusing on diseases where advanced knowledge can improve health outcomes, whether by changing behavior, pursuing preventative measures, or preparing for what lies ahead.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Counsyl company profile →
Citation Growth
HQ: Canada
Website
- Description: Provider of cannabis cultivation, processing, and branding services, producing high-quality cannabis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Citation Growth company profile →
GenArraytion
HQ: United States
Website
- Description: Provider of medical diagnostics products and services for tick- and mosquito-borne disease and surveillance, epidemiology and source tracking, food and water testing, biodefense and environmental monitoring, including MultiFLEX Bioassays and Sniper Sequencing genotyping services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenArraytion company profile →
Geneseeq
HQ: Canada
Website
- Description: Provider of NGS-based genomic testing and research services for cancer care, offering pan-cancer and tumor-specific panels plus project design, sequencing and data analysis. Products include GeneseeqPrime™ (437-gene solid tumor panel with mutation, tumor mutational burden and DNA mismatch repair insights), GeneseeqPrime™ HRD for PARP inhibitor guidance, Hemasalus™ DNA/Hemarna™ RNA for hematological cancers, and Shielding™ ULTRA MRD ctDNA detection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Geneseeq company profile →
OralDNA Labs
HQ: United States
Website
- Description: Provider of salivary diagnostics services to treat, heal, and inspire oral health, offering a wide range of tests including DNA polymerase chain reaction (PCR) and next-generation sequencing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OralDNA Labs company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Parse Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Parse Biosciences
2.2 - Growth funds investing in similar companies to Parse Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Parse Biosciences
4.2 - Public trading comparable groups for Parse Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →